Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 20/20 | 0.56 |
| ▸ | PPARA | Q07869 | 20/20 | 0.56 |
| ▸ | PPARG | P37231 | 15/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5511703 | 0.93 | PPARA (0.57) | PPARDPPARAPPARG | |
| SCHEMBL1011033 | 0.91 | PPARA (0.53) | PPARDPPARAPPARG | |
| SCHEMBL1010183 | 0.86 | PPARD (0.54) | PPARDPPARAPPARG | |
| SCHEMBL1010591 | 0.86 | PPARA (0.49) | PPARDPPARAPPARG | |
| SCHEMBL1012218 | 0.85 | PPARA (0.56) | PPARDPPARAPPARG | |
| SCHEMBL1008833 | 0.82 | PPARA (0.52) | PPARDPPARAPPARG | |
| SCHEMBL1009736 | 0.82 | PPARA (0.55) | PPARDPPARAPPARG | |
| SCHEMBL1009258 | 0.82 | PPARA (0.48) | PPARDPPARAPPARG | |
| SCHEMBL1012230 | 0.82 | PPARD (0.45) | PPARDPPARAPPARG | |
| SCHEMBL1010688 | 0.80 | PPARD (0.52) | PPARDPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2484361-B1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO (JP) | 2015-11-11 | — | — | EP | claimed |
| US-20120165377-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2012-06-28 | — | — | US | claimed |
| US-20230321051-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230019803-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20210205274-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2021-07-08 | — | — | US | disclosed |
| US-20200246315-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2020-08-06 | — | — | US | disclosed |
| US-20200030299-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2020-01-30 | — | — | US | disclosed |
| US-20190167644-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO. LTD. (JP) | 2019-06-06 | — | — | US | disclosed |
| US-20180078530-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2018-03-22 | — | — | US | disclosed |
| US-20160243086-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| EP-2484361-B1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO (JP) | 2015-11-11 | — | — | EP | disclosed |
| EP-2484361-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | Kowa Company, Ltd. (JP) | 2012-08-08 | — | — | EP | disclosed |
| US-20120165377-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | KOWA CO., LTD. (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210205274-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 67/4885PPARA 20/4885PPARG 32/4885 |
| US-20200030299-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 67/4885PPARA 20/4885PPARG 32/4885 |
| US-20180078530-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 67/4885PPARA 20/4885PPARG 32/4885 |
| US-20230321051-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 68/4885PPARA 22/4885PPARG 35/4885 |
| US-20230019803-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 67/4885PPARA 20/4885PPARG 32/4885 |
| US-20190167644-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, CPT1B | PPARD 66/4885PPARA 21/4885PPARG 33/4885 |
| US-20160243086-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 67/4885PPARA 20/4885PPARG 32/4885 |
| US-20120165377-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 67/4885PPARA 20/4885PPARG 32/4885 |
| US-20200246315-A1 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | FABP4, FGF1, FGFR1 | PPARD 64/4885PPARA 21/4885PPARG 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.